Rights and permissions
About this article
Cite this article
Hypolipaemic treatment is more cost-effective with simvastatin than with cholestyramine. Inpharma Wkly. 739, 5–6 (1990). https://doi.org/10.2165/00128413-199007390-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007390-00011